STAT

JANUARY 30, 2023

The federal government will audit Medicare Advantage insurers aggressively under a rule finalized Monday, which is expected to result in billions of dollars in overpayments going back toward Medicare’s trust fund and patients over the next decade. However, federal officials watered down one of the auditing policies by giving insurers seven years of immunity from having the samples of their diagnosis coding errors extrapolated to their broader Medicare Advantage membership.

Immunity 355

Immunity Immunization 355

PharmaVoice

JANUARY 30, 2023

Why an alliance of industry leaders is exploring the potential of social media as a treasure trove of real-world patient experience insights.

246

246

Pharmaceutical Technology

FEBRUARY 3, 2023

Only a few weeks into the new year, the prospect of getting a successful advanced HIV vaccine shrank after the discontinuation of yet another late-stage trial. On January 18, Janssen, a Johnson & Johnson (J&J) subsidiary, stated that its vaccine was not effective in preventing HIV infections. This marks the second time one of Janssen’s HIV vaccines failed after another showed disappointing results in the Phase IIb Imbokodo trial in August 2021.

Vaccines 117

Vaccines Immunity Immunization 117

Pharma Times

JANUARY 30, 2023

Acepiro tablets for respiratory diseases will be available across the UK prescription market

131

131

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

FEBRUARY 1, 2023

A recent study and accompanying news story in the preeminent journal Nature provocatively concludes that disruptive innovation in science has dramatically and mysteriously declined 90% since 1945. The study has prompted a wave of news coverage and tweets decrying the apparent languishing of modern science. We feel that the authors make interesting observations on publishing trends, but their conclusions seem to be quite disconnected from the valuable and transformative innovations that benefit h

350

350

PharmaVoice

JANUARY 31, 2023

With the industry focused on cancer and COVID-19, Marc de Garidel made deals centered on cardio.

290

290

Med Ed 101

FEBRUARY 1, 2023

There are literally thousands of drug interactions so I had my work cut out to try to narrow down the list to the top 10. In this post, I outline my list of the top 10 drug interactions. This is based on a combination of my experience, the frequency of the interaction, the severity of […] The post Top 10 Drug Interactions – My List appeared first on Med Ed 101.

98

98

STAT

FEBRUARY 2, 2023

WASHINGTON — A majority of Americans support banning all tobacco products, according to a new poll published by researchers at the Centers for Disease Control and Prevention. The survey , which was published Thursday in the peer-reviewed journal Preventing Chronic Disease, asked 6,455 people nationwide: “To what extent would you support a policy to prohibit the sale of all tobacco products?

315

315

PharmaVoice

JANUARY 31, 2023

The biotech aims to complete rolling submissions with regulators in the U.K. and Australia in the first half of 2023.

Vaccines 264

Vaccines 264

Pharmaceutical Technology

FEBRUARY 1, 2023

Pfizer has reported a 30% operational growth in revenues to $100.3bn in full-year 2022 compared with $81.2bn reported last year. The revenues grew 2% operationally excluding Paxlovid and Comirnaty’s contributions. In the fourth quarter (Q4) of 2022, they increased 13% operationally to $24.3bn compared to $23.8bn in the same quarter last year. On an operational basis, the revenues rose by 5%, omitting contributions from Paxlovid and Comirnaty.

104

104

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

Board Vitals - Pharmacist

JANUARY 31, 2023

On February 12, the Philadelphia Eagles and Kansas City Chiefs will duke it out in Super Bowl LVII. In addition to the players on the field, there are teams of NFL team doctors and sports medicine specialists who keep the offenses, defenses, and special teams in top shape. According to the NFL Physicians Society (NFLPS), 192 team physicians (as of 2023) provide care to the 32 NFL teams and their players – on and off the field, and long before and after game time.

Medical Schools 98

Medical Schools Communication Hospitals 98

STAT

FEBRUARY 2, 2023

Inferior vena cava filters are supposed to save lives. The spider-like devices catch blood clots before they can travel up to the lung and cause deadly pulmonary embolisms. But for over a decade, these devices have been dogged by questions about how well they work and the serious complications they can cause for patients. The latest data make clear they’re still causing problems: Researchers examined a Food and Drug Administration database and found that adverse event reports related to t

306

306

PharmaVoice

JANUARY 30, 2023

Download the complimentary Guide to Successful Copay Programs that delivers actionable insights to pharma leaders.

246

246

Pharmaceutical Technology

FEBRUARY 2, 2023

If things go as per plan, in a few months, the US Food and Drug Administration (FDA) will deliberate on the first-of-its-kind CRISPR-based gene therapy for sickle cell disease (SCD) and transfusion-dependent beta thalassemia. Having made significant advances in a relatively short period of time, CRISPR research is now edging closer to reaching the clinic , and this month’s cover story takes a look at the major players in this field and the big events that could break through this year.

98

98

The Luxe Pharmacist

JANUARY 30, 2023

As many of you know I’ve been on a bit of a health kick since the end of October, so I’m not necessarily creating new resolutions for 2023 when it comes to health. Instead, this year is about continuing my commitment to physical and mental wellness. As a whole this involves obviously many different aspects of my life and daily habits but today I wanted to talk about one area in particular, gut health.

Immunity 98

Immunity Immunization Customer Service Dosage 98

STAT

JANUARY 31, 2023

Stressful experiences during early childhood — particularly economic strife — appear to act as a toxic stressor that can alter regions of the brain tied to the processing of stress and trauma, according to a new study published Wednesday. The researchers found that Black children were impacted more than white children, largely because of the higher amounts of poverty and adversity they face.

300

300

PharmaVoice

FEBRUARY 2, 2023

The FTC and DOJ are heightening antitrust enforcement, and pharma deals are a prime target.

240

240

Pharmaceutical Technology

FEBRUARY 3, 2023

Merck (MSD outside North America) has reported a 2% increase in worldwide sales to $13.83bn in the fourth quarter (Q4) of 2022 from $13.52bn in the previous year’s quarter. The company’s pharmaceutical sales recorded a 1% rise to $12.18bn compared to $12.03bn in the prior-year quarter. For the quarter, GAAP earnings per share (EPS) from continuing operations was $1.18, indicating a 22% decline from $1.5 in the same quarter last year.

Vaccines 98

Vaccines 98

Pharma Times

FEBRUARY 1, 2023

UK-wide therapy for patients who have seizures linked to tuberous sclerosis complex

132

132

STAT

FEBRUARY 1, 2023

Medicare Advantage insurers could face an average 2.3% cut to baseline payments in 2024, the Biden administration said Wednesday. If the proposal stands, it would be a net cut of more than $3 billion to the industry. The major reason behind the proposed pay cut: Medicare officials want to update data and coding systems that are used to explain the health conditions of an insurance company’s enrollees.

295

295

PharmaVoice

JANUARY 30, 2023

Emerging channels offer new ways to reach key targets and improve campaign ROI.

246

246

Pharma Pathway

JANUARY 28, 2023

Zydus -Walk-In Interviews for Production/ Packing/ Warehouse/ QC On 29th Jan’ 2023 Job Description Inviting Candidates for a walk-In Interview for Formulations Manufacturing plat (OSD), Matoda, Ahmedabad On 29th Jan’ 2023. The Interview will take place at Ahmedabad District. We are recruiting for Formulation Manufacturing Plant (OSD) at SEZ -1 (Matoda), Ahmedabad Departments: Production/ Packing/ Warehouse/ QC Term Employee: ITI/ Diploma Engineer/ Pharmacy With 1-4 years of experience Inte

Documentation 96

Documentation 96

Pharma Times

FEBRUARY 2, 2023

The central focus of the agreement is to establish peptide hits from selected library populations

121

121

STAT

JANUARY 30, 2023

The federal government and health insurance companies have been clashing for more than a decade over how Medicare Advantage plans should be audited and how the well-documented overpayments to those plans should be clawed back. That fight is about to hit an inflection point this week, when Medicare makes a final determination about how aggressively it will probe the industry.

Health Insurance Companies 279

Health Insurance Companies Documentation 279

PharmaVoice

FEBRUARY 1, 2023

The VP of medical affairs and women's health is focused on an audacious goal — to meet the needs of 100 million women in lower income countries.

130

130

European Pharmaceutical Review

FEBRUARY 3, 2023

Switzerland-based contract development and manufacturing organisation (CDMO) CARBOGEN AMCIS has opened a new facility in France, dedicated to the custom development and production of sterile injectable drug products. The facility forms two new fully-automated production lines for liquid and freeze-dried drugs, including highly potent compounds and advanced therapies such as antibody drug conjugates (ADCs).

Dosage 93

Dosage Compounding Pharmaceutical Companies Pharmaceutical Companies 93

pharmaphorum

JANUARY 29, 2023

What do I mean by vital acceleration? With the population ageing, the need for healthcare is growing fast: between 2015 and 2050, the proportion of the world’s population over 60 years old will nearly double from 12% to 22%, according to the World Health Organization. Keeping our elderly population healthy will prove a major challenge in years to come.

Nursing Homes 92

Nursing Homes Hospitals Vaccines 92

STAT

FEBRUARY 2, 2023

NEW YORK — U.S. health officials are advising people to stop using over-the-counter eye drops that have been linked to an outbreak of drug-resistant infections. The Centers for Disease Control and Prevention on Wednesday night sent a health alert to physicians, saying the outbreak includes at least 55 people in 12 states. One died.

274

274

PharmaVoice

FEBRUARY 1, 2023

With positive early phase data, CEO Jill Milne is aiming to bring an improved preventative option to patients with hereditary angioedema.

130

130

Pharma Times

FEBRUARY 2, 2023

Boost concerns rapid deployment of novel detection reagents for testing in low to middle-income countries

113

113

European Pharmaceutical Review

JANUARY 30, 2023

Jaypirca (pirtobrutinib) has been approved by the US Food and Drug Administration (FDA), making it the first and only FDA-approved non-covalent (reversible) Bruton’s tyrosine kinase (BTK) inhibitor. It is indicated for adults with relapsed or refractory mantle cell lymphoma (MCL) after at least two lines of systemic therapy, including a BTK inhibitor.

91

91

STAT

FEBRUARY 1, 2023

Not long after the artificial intelligence company OpenAI released its ChatGPT chatbot, the application went viral. Five days after its release, it had garnered 1 million users. Since then, it has been called world-changing , a tipping point for artificial intelligence, and the beginning of a new technological revolution. Like others, we began exploring potential medical applications for ChatGPT, which was trained on more than 570 gigabytes of online textual data, extracted from sources like boo

274

274

PharmaVoice

JANUARY 30, 2023

GLP-1 agonists are dominating the anti-obesity scene — but hurdles remain to their uptake.

147

147

Pharma Times

FEBRUARY 1, 2023

Binders will establish cell types and delivery vehicles may increase uptake of the siRNA therapy

118

118

European Pharmaceutical Review

JANUARY 31, 2023

A new strategy for 2023-2025 by the Medicines Patent Pool (MPP) aims to reduce access inequities, by improving the availability and affordability of health products in low- and middle-income countries (LMICs). The MPP is a United Nations-backed public health organisation working to increase medicine access and facilitate the development of life-saving medicines for LMICs.

Communication 91

Communication Vaccines 91